Janssen Reports Positive Phase III Data for Chronic Diabetic Peripheral ... 
Genetic Engineering News
Janssen Pharmaceuticals reported Phase III results demonstrating the efficacy of Nucynta® ER (extended release tapentadol) in managing pain associated with chronic diabetic peripheral neuropathy (DPN). Janssen says the data is consistent with that of a ...
Positive Ph III results for J&J's Nucynta in diabetic peripheral neuropathy The Pharma Letter
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... PR Newswire (press release)

all 4 news articles » 

Tapentadol ER Effective for Moderate to Severe Chronic Diabetic Peripheral ... 
Monthly Prescribing Reference
HONOLULU, HI?Tapentadol extended-release (ER) is a safe and effective option for the management of moderate to severe neuropathic pain associated with diabetic peripheral neuropathy (DPN), investigators reported at the American Pain Society's 31 st ...
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... PipelineReview.com (press release)
J&J's Nucynta tackles pain in people with diabetes PMLiVE

all 10 news articles » 

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... 
MarketWatch (press release)
Over time, people with diabetes can develop a type of nerve damage called neuropathy. Approximately 60 to 70 percent of people with diabetes have some form of neuropathy(3). The most common type is diabetic peripheral neuropathy, which causes pain or ...

and more » 

Neuro diagnosis can ignite grief, mourning 
Hometownlife.com
Perhaps it is multiple sclerosis or Parkinson's disease or epilepsy or Huntington's disease or peripheral neuropathy. Or, for that matter, any other serious medical or psychological diagnosis. You can't flee. You can't protect yourself.

 

Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin ... 
MarketWatch (press release)
NEW YORK, May 04, 2012 (BUSINESS WIRE) -- Pfizer Inc. (NYSE:PFE) announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet ...
Pfizer halts Lyrica Phase 3 Trial In Neuropathic Pain related to HIV Neuropathy RTT News
Pfizer's Lyrica Fails In Inadequately Treated PDPN; Trial For New Use Halted NASDAQ
Pfizer Axes Late-Stage Lyrica Study Following Disappointing Results Fox Business
Chicago Tribune  -Wall Street Journal 
all 156 news articles » 

National Poll Shows Delayed Diagnosis, Inadequate Pain Care, and Distressing ... 
San Francisco Chronicle (press release)
A new national Neuropathy Association poll of peripheral neuropathy patients finds that the majority of respondents experience an extended period of time from symptom onset to diagnosis of their neurological disease, with 57% taking two or more years ...

and more » 

Diabetes and the Beaver 
Meriden Record-Journal
But peripheral neuropathy, in my case, is no big deal, so I'm really not complaining. Honest. In my case, it's mainly a matter of numbness in the fingers and toes, plus a bit of additional clumsiness (that is, additional to my natural clumsiness).

 

Competitive Technologies Announces Results of Pilot Trials Using Calmare(R ... 
MarketWatch (press release)
One study is on patients suffering from chemotherapy-induced peripheral neuropathy (CIPN) and the other is on patients suffering from post-herpetic neuropathy (PHN). The first abstract from authors at Mayo Clinic and Johns Hopkins University says, ...

and more » 

Valley Presbyterian Hospital's Amputation Prevention Center Observes ... 
MarketWatch (press release)
Peripheral neuropathy usually affects the hands and feet, causing weakness, numbness, tingling and pain. Peripheral neuropathy can occur at any age, but it is more common among older adults. While there are several causes of neuropathy, diabetes is the ...

and more » 

Slow diabetic neuropathy by keeping blood sugar controlled 
Sioux City Journal
The most common symptoms of neuropathy are tingling, burning, other unpleasant sensations or a loss of sensation. The most common type of nerve damage from diabetes is peripheral neuropathy. It affects the peripheral nerves that extend from your spine ...

and more »